LeonaBio (LONA) Other Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has reported Other Accumulated Expenses for 8 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 46.75% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 46.75% YoY), while the FY2025 annual figure was $2.0 million, down 41.24% from the prior year.
• Other Accumulated Expenses retreated to $1.3 million in Q1 2026 per LONA's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $11.9 million in Q4 2023 and bottomed at $738000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $5.7 million across 5 years, with a median of $5.1 million in 2022.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 210.07% — and 2025, when it sank 90.86%.
• LeonaBio's Other Accumulated Expenses stood at $3.8 million in 2022, then soared by 210.07% to $11.9 million in 2023, then slumped by 71.27% to $3.4 million in 2024, then tumbled by 41.24% to $2.0 million in 2025, then tumbled by 33.7% to $1.3 million in 2026.
• Business Quant data shows LONA's Other Accumulated Expenses at $1.3 million in Q1 2026, $2.0 million in Q4 2025, and $738000.0 in Q3 2025.